EMD-60274
SARS-CoV-2 XBB.1.5 spike glycoprotein trimer in complex with antigen-binding fragments (Fabs)
EMD-60274
Single-particle3.76 Å
Deposition: 27/05/2024Map released: 06/11/2024
Last modified: 21/05/2025
Sample Organism:
SARS-CoV-2,
Homo sapiens
Sample: SARS-CoV-2 XBB.1.5 spike glyco protein-human Fab complex
Deposition Authors: Sugita Y
,
Kimura K ,
Noda T ,
Hashiguchi T
Sample: SARS-CoV-2 XBB.1.5 spike glyco protein-human Fab complex
Deposition Authors: Sugita Y
,
Kimura K ,
Noda T ,
Hashiguchi T
Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection case.
Kuwata T,
Kaku Y ,
Biswas S,
Matsumoto K,
Shimizu M,
Kawanami Y,
Uraki R,
Okazaki K,
Minami R,
Nagasaki Y,
Nagashima M,
Yoshida I,
Sadamasu K,
Yoshimura K,
Ito M,
Kiso M,
Yamayoshi S,
Imai M,
Ikeda T,
Sato K,
Toyoda M,
Ueno T,
Inoue T,
Tanaka Y,
Kimura KT,
Hashiguchi T ,
Sugita Y ,
Noda T ,
Morioka H,
Kawaoka Y,
Matsushita S
(2024) Ebiomedicine , 110 , 105439 - 105439
,
Biswas S,
Matsumoto K,
Shimizu M,
Kawanami Y,
Uraki R,
Okazaki K,
Minami R,
Nagasaki Y,
Nagashima M,
Yoshida I,
Sadamasu K,
Yoshimura K,
Ito M,
Kiso M,
Yamayoshi S,
Imai M,
Ikeda T,
Sato K,
Toyoda M,
Ueno T,
Inoue T,
Tanaka Y,
Kimura KT,
Hashiguchi T ,
Sugita Y ,
Noda T ,
Morioka H,
Kawaoka Y,
Matsushita S
(2024) Ebiomedicine , 110 , 105439 - 105439
Grant Support: